Andheri East, Mumbai, Maharashtra
- GST NO. : 27AAFCI1065F1ZS
Bevacizumab 400mg16ml Injection
| Business Type | Exporter, Trader |
| Composition | Bevacizumab |
| Indication | Cancer |
| Volume/ Packaging size | 16 ml |
| Click to view more | |
Preferred Buyer From
| Location | Worldwide |
Product Details
Dose/Strength
400mg/16ml
Dosage Form
Injection
Warning/Precaution
Not to be used by pregnant women
Storage
Store at 20°C to 80°C. Do not freeze. Protect from light
Shelf Life
2 Years
Bevacizumab is a recombinant humanized monoclonal IgG1 antibody that binds and inhibits biological activity of human vascular endothelial growth factor (VEGF). Bevacizumab has been approved for the treatment of Metastatic Colorectal Cancer (mCRC), Non-Squamous Non-Small Cell Lung Cancer (NSCLC), Glioblastoma, Metastatic Renal Cell Carcinoma (mRCC) or Metastatic Carcinoma of the Cervix, etc.
Looking for "Bevacizumab 400mg16ml Injection" ?
Piece
Explore More Products
